Cargando…

Analysis of Threshold Change of Tumor Mutation Burden in Gastric Cancer

BACKGROUND: The purpose of this study was to investigate the change of tumor mutation burden (TMB) in gastric cancer (GC) and its relationship with prognosis. METHODS: A total of 262 patients with GC from January 2018 to December 2019 were included in this study. All patients were in the advanced st...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xinwei, Yu, Ming, Wang, Xuezhong, Chen, Jixian, Li, Xianglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321718/ https://www.ncbi.nlm.nih.gov/pubmed/34335754 http://dx.doi.org/10.1155/2021/3374939

Ejemplares similares

Analysis of Threshold Changes of Tumor Mutation Burden of Gastric Cancer and Its Relationship with Patients' Prognosis
por: Zhang, Nan, et al.
Publicado: (2021)

Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer
por: Yu, Jie, et al.
Publicado: (2021)

The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy
por: Golkaram, Mahdi, et al.
Publicado: (2020)

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden
por: Ma, Weijun, et al.
Publicado: (2021)

Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
por: Hu, Sizhe, et al.
Publicado: (2021)

A Joint Model Considering Measurement Errors for Optimally Identifying Tumor Mutation Burden Threshold
por: Wang, Yixuan, et al.
Publicado: (2022)

Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer
por: Zhang, Fengxiang, et al.
Publicado: (2022)

CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer
por: Huang, Taobi, et al.
Publicado: (2021)

Retracted: Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer
por: Wang, Xuning, et al.
Publicado: (2021)

Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy
por: Duan, Xiao-Peng, et al.
Publicado: (2023)

Fusobacterium Nucleatum-Induced Tumor Mutation Burden Predicts Poor Survival of Gastric Cancer Patients
por: Hsieh, Yung-Yu, et al.
Publicado: (2022)

A machine learning-based radiomics model for prediction of tumor mutation burden in gastric cancer
por: Ma, Tingting, et al.
Publicado: (2023)

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer
por: Guo, Xiong, et al.
Publicado: (2021)

Biological informed graph neural network for tumor mutation burden prediction and immunotherapy-related pathway analysis in gastric cancer
por: Liu, Chuwei, et al.
Publicado: (2023)

Tumor mutation burden and recurrent tumors in hereditary lung cancer
por: Hsu, Yi‐Chiung, et al.
Publicado: (2019)

TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer
por: Yu, Ruili, et al.
Publicado: (2021)

Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer
por: Folprecht, Gunnar
Publicado: (2019)

Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
por: Li, Wenjie, et al.
Publicado: (2022)

Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer
por: Zhao, Dong-Yan, et al.
Publicado: (2021)

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Multiomics analysis of tumor mutational burden across cancer types
por: Li, Lin, et al.
Publicado: (2021)

TMBcat: A multi-endpoint p-value criterion on different discrepancy metrics for superiorly inferring tumor mutation burden thresholds
por: Wang, Yixuan, et al.
Publicado: (2022)

Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers
por: Wang, Min, et al.
Publicado: (2018)

Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study
por: Zhang, Tongchao, et al.
Publicado: (2021)

Prognostic impact of gene copy number instability and tumor mutation burden in patients with resectable gastric cancer
por: Cai, Lisheng, et al.
Publicado: (2020)

Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients
por: Xiang, Li, et al.
Publicado: (2022)

Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA
por: Sasaki, Noriyuki, et al.
Publicado: (2020)

MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
por: Yang, Yue, et al.
Publicado: (2020)

Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate
por: Zhang, Wensheng, et al.
Publicado: (2017)

Chinese and global burdens of gastric cancer from 1990 to 2019
por: He, Yuxin, et al.
Publicado: (2021)

Insights into gastric neuroendocrine tumors burden
por: Thomaz Araújo, Taíssa Maíra, et al.
Publicado: (2017)

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2021)

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
por: Kim, Jinchul, et al.
Publicado: (2020)

Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer
por: Wei, Cheng, et al.
Publicado: (2022)

Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden
por: Kim, Hyunjin, et al.
Publicado: (2022)

When genetic burden reaches threshold
por: Walsh, Roddy, et al.
Publicado: (2020)

Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors
por: Wang, Zi‐Ming, et al.
Publicado: (2021)

The burden of gastric cancer
por: Hamashima, Chisato
Publicado: (2020)

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
por: Wang, Peipei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fs9b5v84qaofglotei7riv6spt